Search for: "Amicus Therapeutics US, LLC" Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2023, 10:14 am by Courtenay C. Brinckerhoff
GlaxoSmithKline, LLC, which has come to be known as the “skinny label” case. [read post]
6 May 2022, 8:10 am by Dennis Crouch
  This gets a bit complicated when a drug has  multiple therapeutic uses, only some of which are patented. [read post]
1 Feb 2008, 4:06 am
Pettus' firm represented HEXAS LLC, The Roskamp Institute, and Tikvah Therapeutics in an amicus curiae brief filed in Smithkline Beecham Corp. v. [read post]
2 Feb 2008, 12:00 am
Pettus’ firm represented HEXAS LLC, The Roskamp Institute, and Tikvah Therapeutics in an amicus curiae brief filed in Smithkline Beecham Corp. v. [read post]
Seventeen States File Amicus Brief Opposing the Board Diversity Rule On the other hand, 17 states, through their attorneys general, together filed an amicus brief in support of the NCPPR. [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision… [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Acorda Therapeutics, et al., No. 16-360 Anticipation: Grunenthal GmbH v. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Full Scope Written Description in Juno Therapeutics, Inc. v. [read post]
29 Jul 2013, 7:45 am by Schachtman
Harkonen’s use of “demonstrate” to des [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]